The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.
Lisa Christopher-StineAnna CieslukGabriela Arredondo Hector ChinoyNamita A GoyalKaniah GunterDavid Alan IsenbergAdrian KielhornIngrid E LundbergTahseen MozaffarSanjay RakhadeGerrit VandenbergRohit AggarwalPublished in: The Journal of rheumatology (2024)
The DM-DSQ is being used in a phase II clinical trial and could become a valuable tool for studies evaluating PROs in patients with DM. Preliminary results indicate its content validity; extensive psychometric analysis using clinical trial data will determine its ability to capture symptoms for patients with DM.
Keyphrases
- clinical trial
- phase ii
- open label
- interstitial lung disease
- double blind
- glycemic control
- phase iii
- study protocol
- placebo controlled
- disease activity
- patient reported
- randomized controlled trial
- sleep quality
- cross sectional
- electronic health record
- case control
- depressive symptoms
- systemic lupus erythematosus
- idiopathic pulmonary fibrosis